Mark C. Brister,Nelson Quintana,Kaushik A. Patel,Neil R. Drake,Antonio C. LIevares,Dubravka Markovic,Andrew P. Rasdal,Amy D.L. VandenBerg
申请号：
US14469442
公开号：
US20140364894A1
申请日:
2014.08.26
申请国别(地区):
US
年份:
2014
代理人:
摘要：
An implant configured for ingestion by a patient. After the implant has been swallowed by the patient and is disposed within the target location, e.g. the patient's stomach, an inflation subcomponent causes the implant to expand from a compact delivery state to an expanded, volume-occupying, deployed state. In the deployed state the implant creates a sensation of satiety in the patient stomach and thereby aids in limiting food intake and obesity. After a predetermined time a deflation subcomponent is actuated and the implant reduces in size so as to allow it to pass through the remainder of the patient's digestive track. The device may further incorporate tracking and visualization subcomponents, as well as pharmaceutical delivery subcomponents.
